Theradiag S.A. (ALTER)の価格はいくらですか

Theradiag S.A. (ALTER)の価格は$1.38です

Theradiag S.A. (ALTER)の時価総額は何ですか

Theradiag S.A. (ALTER)の時価総額は$12.52Mです

Theradiag S.A.（ALTER）PER（株価収益率）

Theradiag S.A. specializes in the creation, production, and marketing of in-vitro diagnostic solutions. Its product line encompasses reagents for autoimmune conditions, IMMUNO-TROL — a comprehensive quality control tool with multiple parameters — and various instruments for testing both autoimmune disorders and infectious diseases. Among its unique offerings are the SQA-V system, engineered for semen analysis, and V-Sperm, a specialized application for digitally uploading and viewing sample results, including pictures and video recordings. The company's advanced instrumentation includes Theralis, which integrates multiplex FIDIS immunofluorescence with ELISA capabilities; Theralis µ, designed as a suitable solution for mid-sized laboratories; and the FIDIS platform, utilized for diverse laboratory analyses. Furthermore, Theradiag provides therapeutic drug monitoring services aimed at managing chronic inflammatory conditions. It also offers LISA tracker, an essential device for overseeing biotherapies, alongside both ELISA and rapid serological tests for SARS-CoV-2. Founded in 1986, Theradiag S.A. is based in Marne La Vallee, France.

年	P/E比率	変化
提供された日付のデータは十分ではありません。

年

P/E比率

変化

提供された日付のデータは十分ではありません。

企業	P/E比率	P/E比率の差	国
Abbott Laboratories ABT.US	35.77	-	US
Stryker Corporation SYK.US	34.86	-	US
Medtronic plc MDT.US	21.39	-	IE
Boston Scientific Corporation BSX.US	20.90	-	US
Edwards Lifesciences Corporation EW.US	52.64	-	US

企業

P/E比率

P/E比率の差

国